Craft

Innovent Biologics

Stock Price

$37.2

2024-10-29

Market Capitalization

$57.6 B

2024-10-29

Revenue

¥13 B

FY, 2025

Innovent Biologics Summary

Company Summary

Overview
Innovent Biologics is a biopharmaceutical company that develops and manufactures drugs. It offers monoclonal antibody drug candidates for the treatment of oncology, ophthalmology, autoimmune, cardiovascular, and other diseases.
Type
Public
Status
Active
Founded
2011
HQ
Suzhou, CN | view all locations
Website
https://www.innoventbio.com
Cybersecurity rating
Sectors

LocationsView all

1 location detected

  • Suzhou, Jiang Su Sheng HQ

    China

    No. 168, Dongping Street, Industrial Park

Innovent Biologics Financials

Summary Financials

Revenue (FY, 2025)
¥13.0B
Gross profit (FY, 2025)
¥12.0B
Net income (FY, 2025)
¥813.6M
Cash (FY, 2025)
¥17.3B
EBIT (FY, 2025)
¥726.1M
Enterprise value
$43.1B

Footer menu